The $17 billion contract research organization (CRO) market is growing 15% annually. CROs currently perform approximately 25% of preclinical drug testing for pharmaceutical manufacturers, and analyst Isaac Ro of Leerink Swann predicts that, due to imminent strains on pharmaceutical firms including lower profits and more regulations, within three years the number will double to 50%. […]
Austin, TX 7/7/08—Xenemetrix announced that on June 15 it acquired Jordan Valley’s Analytical Instrument Division, which suppliers energy dispersive–X-ray fluorescence spectroscopy instruments (ED-XRF). Xenemetrix was formed by a private management group, led by CEO Doron Reinis, a founding partner of Business Processes, a consulting, production engineering and industrial engineering services firm. “As Jordan Valley Semiconductors […]
China’s State Food and Drug Administration (SFDA) reports that at the end of 2007 there were 6,913 pharmaceutical companies in the country, including 4,682 active pharmaceutical ingredient and preparation manufacturers. The Chinese pharmaceutical market is composed of seven subindustries: “Chinese patent medicines, prepared slices of Chinese crude drugs, bulk chemical drug substances, chemical drug preparations, […]
Company Announcements In May, Invitrogen licensed human embryonic stem cell (hESC) patents from the Wisconsin Alumni Research Foundation for the development of research tools, giving it the right to work with karyotypically normal hESCs. Agilent acquired a license in May from the Broad Institute to commercialize a method for genome partitioning using Agilent’s Oligo Library […]
San Diego, CA 7/22/08—Illumina has acquired Avantome, the developer of a long read-length sequencing technology, for $25 million in cash and contingent payments of up to $35 million. Avantome’s principal founders Mostafa Ronaghi and Helmy Eltoukhy will join Illumina. Dr. Ronaghi will serve as senior vice president and chief technical officer and Dr. Eltoukhy will […]
Disappointing economic news continued to weigh on the US markets this month. On July 31, the US reported second-quarter economic growth of 1.9%, compared to economists’ expectations of 2.3%. The US also lowered its GDP estimates for the first quarter of this year and the fourth quarter of 2007 to 0.9% and negative 0.2%, respectively. […]
A new report by the US International Trade Commission (USITC) examines two segment of the US industrial biotech market, liquid biofuels and bio-based chemicals, based on a survey of 559 establishments with production or R&D activities related to liquid fuel or chemicals. Respondents’ US sales of US-produced liquid biofuels increased 140% from 2004 to 2007 […]
Despite the economic downturn, sales of analytical and life science instruments and related aftermarket products and service have remained healthy. Steady industrial end-markets, demand from Asia, and robust biotech and contract research organization (CRO) sales have offset cautious spending by big pharma and a mixed academic market. As the table on page 3 shows, first-half […]
Waltham, MA 7/7/08—Thermo Fisher Scientific has acquired Affinity BioReagents, a provider of more than 35,000 reagents for life science research, including antibodies, peptides and proteins, with 2007 revenues of $6 million. Financial details were not provided. “This acquisition enhances our extensive antibody portfolio, which will drive growth as we combine these reagents with our current […]
Growth for India’s biotech sector has decelerated from the compound annual growth rate of 34% in the past five years to a 20% rate for 2007–2008, recording nearly $2.5 billion in revenues, according to a survey by the Association of Biotech Led Enterprises and Biospectrum magazine. The biotech sector is divided into five segments: biopharma, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
